565 related articles for article (PubMed ID: 19546583)
1. Influence of dual blockade of the renin-angiotensin system on thirst in hemodialysis patients.
Masajtis-Zagajewska A; Nowicki M
Nephron Clin Pract; 2009; 112(4):c242-7. PubMed ID: 19546583
[TBL] [Abstract][Full Text] [Related]
2. Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.
Bots CP; Brand HS; Veerman EC; Korevaar JC; Valentijn-Benz M; Bezemer PD; Valentijn RM; Vos PF; Bijlsma JA; ter Wee PM; Van Amerongen BM; Nieuw Amerongen AV
Nephrol Dial Transplant; 2005 Mar; 20(3):578-84. PubMed ID: 15665029
[TBL] [Abstract][Full Text] [Related]
3. Three months of regular gum chewing neither alleviates xerostomia nor reduces overhydration in chronic hemodialysis patients.
Jagodzińska M; Zimmer-Nowicka J; Nowicki M
J Ren Nutr; 2011 Sep; 21(5):410-7. PubMed ID: 21185739
[TBL] [Abstract][Full Text] [Related]
4. Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: evidence from an observational study and a pilocarpine clinical trial.
Sung JM; Kuo SC; Guo HR; Chuang SF; Lee SY; Huang JJ
J Am Soc Nephrol; 2005 Nov; 16(11):3418-29. PubMed ID: 16177001
[TBL] [Abstract][Full Text] [Related]
5. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
Han SW; Won YW; Yi JH; Kim HJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
[TBL] [Abstract][Full Text] [Related]
6. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
7. The dual blockade of the renin-angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration.
Zwiech R; Bruzda-Zwiech A
Int Urol Nephrol; 2013 Oct; 45(5):1365-72. PubMed ID: 23136031
[TBL] [Abstract][Full Text] [Related]
8. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst.
Bots CP; Brand HS; Veerman EC; Valentijn-Benz M; Van Amerongen BM; Valentijn RM; Vos PF; Bijlsma JA; Bezemer PD; Ter Wee PM; Amerongen AV
Kidney Int; 2004 Oct; 66(4):1662-8. PubMed ID: 15458464
[TBL] [Abstract][Full Text] [Related]
9. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
10. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
11. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
12. Thirst, interdialytic weight gain, and thirst-interventions in hemodialysis patients: a literature review.
Mistiaen P
Nephrol Nurs J; 2001 Dec; 28(6):601-4, 610-3; quiz 614-5. PubMed ID: 12143470
[TBL] [Abstract][Full Text] [Related]
13. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
Chrysostomou A; Pedagogos E; MacGregor L; Becker GJ
Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of long-term use of angiotensin-converting enzyme inhibitors by hemodialysis patients on thirst and fluid weight gain.
Hamad A; Khosrovaneh A; Gupta S; Fazal S; Manis T; Feinfeld DA
Ren Fail; 2002 Jul; 24(4):461-6. PubMed ID: 12212825
[TBL] [Abstract][Full Text] [Related]
16. Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients.
Bruzda-Zwiech A; Szczepańska J; Zwiech R
Med Oral Patol Oral Cir Bucal; 2018 Jul; 23(4):e406-e412. PubMed ID: 29924756
[TBL] [Abstract][Full Text] [Related]
17. Oral and salivary changes in patients with end stage renal disease (ESRD): a two year follow-up study.
Bots CP; Brand HS; Poorterman JH; van Amerongen BM; Valentijn-Benz M; Veerman EC; ter Wee PM; Nieuw Amerongen AV
Br Dent J; 2007 Jan; 202(2):E3. PubMed ID: 17235362
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Donner KM; Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Tikkanen I; Antikainen M; Hirvonen A; Kontula K
J Hypertens; 2009 Oct; 27(10):2001-9. PubMed ID: 19593208
[TBL] [Abstract][Full Text] [Related]
19. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
20. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
Banerjee D; Brincat S; Gregson H; Contreras G; Streather C; Oliveira D; Nelson S
Nephrol Dial Transplant; 2006 Apr; 21(4):975-8. PubMed ID: 16384830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
